» » »

Colcrys for Acute Gout Boone NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Appalachian - New River Veterinary Associates
(828) 264-5621
218 Wilson Dr
Boone, NC

Data Provided by:
Dean Steven Cohen
(828) 262-4200
336 Deerfield Rd
Boone, NC
Specialty
Family Practice

Data Provided by:
Charlie L Sykes
(828) 264-6362
108 Doctors Dr
Boone, NC
Specialty
Internal Medicine

Data Provided by:
Thomas J Zuber
(828) 262-1800
245 Winklers Creek Rd
Boone, NC
Specialty
Family Practice, Geriatric Medicine

Data Provided by:
Bill J Beason
(828) 264-4533
237 Longvue Dr
Boone, NC
Specialty
Family Practice

Data Provided by:
Robert C Snyder
(828) 268-0064
237 Longvue Dr
Boone, NC
Specialty
Internal Medicine

Data Provided by:
Juan Carlos De Virgiliis
(828) 262-3733
381 Deerfield Rd
Boone, NC
Specialty
Family Practice

Data Provided by:
Robert Finch Griffith
(828) 262-0060
136 Furman Rd
Boone, NC
Specialty
Internal Medicine

Data Provided by:
William Adam Derrick Jr, MD
A S U Medical Ctr
Boone, NC
Specialties
Pediatrics, Adolescent Medicine-Pediatrics
Gender
Male
Education
Medical School: Med Univ Of Sc Coll Of Med, Charleston Sc 29425
Graduation Year: 1965

Data Provided by:
Nicholas Joseph Placentra
(828) 264-7311
240 Highway 105 Ext Ste 100
Boone, NC
Specialty
Family Practice

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com